Site Listing

Please choose the site that is most convenient for you

Study Name: Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthriti
38 locations found